Open Nav

General Probiotics Inc.

  • Yiannis Kaznessis, General Probiotics Inc.

Biotechnology company focused on developing and commercializing antimicrobial probiotic medicines for the treatment of infectious diseases. The company has been awarded Small Business Innovative Research grant by the National Science Foundation to pursue research and development of drugs to replace antibiotics, since bacteria are developing resistance to current antibiotics. This treatment is targeted towards agriculture markets to improve livestock health and provide safe food products, as well as reducing antibiotic usage that contributes to the drug-resistant bacteria levels currently threatening public health.

  • Date:Tuesday, July 9
  • Time:11:15 AM - 11:30 AM
  • Room:Booth 400
  • Location:Booth 400, Exhibition Hall
  • Session Type:Start-Up Stadium
Speakers
Yiannis Kaznessis
General Probiotics Inc.
Back